Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35741| Title: | Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care. | Authors: | Casan J.M.;Hawkes E.A.;Shortt J. ;Barraclough A. | Institution: | (Casan) Haematology Department, Monash Health, Melbourne, VIC, Australia (Casan, Shortt) School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia (Barraclough, Hawkes) The Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia | Issue Date: | 28-Feb-2019 | Copyright year: | 2019 | Publisher: | Elsevier Ltd | Place of publication: | United Kingdom | Publication information: | The Lancet Haematology. 6 (3) (pp e119), 2019. Date of Publication: March 2019. | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1016/S2352-3026%2819%2930013-4 | PubMed URL: | 30824036 [http://www.ncbi.nlm.nih.gov/pubmed/?term=30824036] | ISSN: | 2352-3026 (electronic) | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/35741 | Type: | Letter | Type of Clinical Study or Trial: | Opinion, perspective or news |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.